Company Encyclopedia
View More
name
SiNtx Tech
SINT.US
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc.
1.392 T
SINT.USMarket value -Rank by Market Cap -/-

Financial Score

29/12/2025 Update
E
Health Care EquipmentIndustry
Industry Ranking174/175
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-343.31%E
    • Profit Margin-775.12%E
    • Gross Margin44.71%B
  • Growth ScoreE
    • Revenue YoY-60.89%E
    • Net Profit YoY-42.17%D
    • Total Assets YoY0.54%C
    • Net Assets YoY-27.11%E
  • Cash ScoreE
    • Cash Flow Margin-7.67%D
    • OCF YoY-60.89%E
  • Operating ScoreE
    • Turnover0.11E
  • Debt ScoreD
    • Gearing Ratio64.20%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CIO Makes Bold Move with Major Stock Purchase in Sintx Technologies

    CIO Gregg R. Honigblum purchased 8,200 shares of Sintx Technologies, indicating confidence in its future. Sintx signed a supply agreement with Evonik for AI-assisted implant manufacturing, despite a Q3 revenue drop. The company focuses on growth following regulatory clearance for its SINAPTIC system. Spark rates SINT as Underperform due to poor financials and bearish technical analysis.

    Tip Ranks·
    US
    SINT
    -2.67%
    Tip Ranks·
    US
    SINT
    -2.67%

    Gregg R. Honigblum, Chief Investment Officer, acquires common shares of SINTX Technologies Inc

    Gregg R. Honigblum, Chief Investment Officer and Director of SINTX Technologies Inc., has acquired common shares of the company. This information was disclosed through a filing on the U.S. SEC's EDGAR system. The news is generated by Public Technologies using AI and is for informational purposes only.

    Reuters·
    US
    SINT
    -2.67%
    Reuters·
    US
    SINT
    -2.67%

    SINTX Technologies Inc. Chief Investment Officer Gregg R. Honigblum Acquires Common Shares

    Gregg R. Honigblum, Chief Investment Officer of SINTX Technologies Inc., has acquired common shares of the company. This acquisition was reported through EDGAR by the U.S. Securities and Exchange Commission on December 08, 2025. The information is provided by Public Technologies using AI and is not financial advice.

    Reuters·
    US
    SINT
    -2.67%
    Reuters·
    US
    SINT
    -2.67%

    SINTX Technologies Signs Supply Agreement With Evonik for Silicon Nitride–PEEK Implant Production

    SINTX Technologies Inc. has signed a supply agreement with Evonik Corporation to produce its silicon nitride-PEEK compound for AI-assisted, 3D-printed, patient-specific implants. This agreement allows SINTX to manufacture custom medical devices at its U.S. facility, with plans to support regulatory clearances for additional implantable devices. The company has received requests for humanitarian-use vertebral body replacement implants for oncology patients.

    Reuters·
    US
    SINT
    -2.67%
    Reuters·
    US
    SINT
    -2.67%

    SiNtx Tech | 8-K: FY2025 Q3 Revenue Beats Estimate at USD 208 K

    LB filings·
    US
    SINT
    -2.67%
    LB filings·
    US
    SINT
    -2.67%
    © 2025 Longbridge｜Disclaimer